Cargando…

Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe

Detalles Bibliográficos
Autores principales: Pardo-Cabello, Alfredo Jose, Manzano-Gamero, Victoria, Luna, Juan de Dios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Federation of Internal Medicine. Published by Elsevier B.V. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922576/
https://www.ncbi.nlm.nih.gov/pubmed/36792428
http://dx.doi.org/10.1016/j.ejim.2023.02.014
_version_ 1784887562812260352
author Pardo-Cabello, Alfredo Jose
Manzano-Gamero, Victoria
Luna, Juan de Dios
author_facet Pardo-Cabello, Alfredo Jose
Manzano-Gamero, Victoria
Luna, Juan de Dios
author_sort Pardo-Cabello, Alfredo Jose
collection PubMed
description
format Online
Article
Text
id pubmed-9922576
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher European Federation of Internal Medicine. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-99225762023-02-13 Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe Pardo-Cabello, Alfredo Jose Manzano-Gamero, Victoria Luna, Juan de Dios Eur J Intern Med Letter to the Editor European Federation of Internal Medicine. Published by Elsevier B.V. 2023-06 2023-02-13 /pmc/articles/PMC9922576/ /pubmed/36792428 http://dx.doi.org/10.1016/j.ejim.2023.02.014 Text en © 2023 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Pardo-Cabello, Alfredo Jose
Manzano-Gamero, Victoria
Luna, Juan de Dios
Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe
title Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe
title_full Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe
title_fullStr Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe
title_full_unstemmed Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe
title_short Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe
title_sort safety of covid-19 vaccines: a comparison between adverse drug reactions among vaccines marketed in europe
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922576/
https://www.ncbi.nlm.nih.gov/pubmed/36792428
http://dx.doi.org/10.1016/j.ejim.2023.02.014
work_keys_str_mv AT pardocabelloalfredojose safetyofcovid19vaccinesacomparisonbetweenadversedrugreactionsamongvaccinesmarketedineurope
AT manzanogamerovictoria safetyofcovid19vaccinesacomparisonbetweenadversedrugreactionsamongvaccinesmarketedineurope
AT lunajuandedios safetyofcovid19vaccinesacomparisonbetweenadversedrugreactionsamongvaccinesmarketedineurope